http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5840328-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac73e460fd686a7a694d3a0a81b03c74 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-557 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-557 |
| filingDate | 1995-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1998-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_971123d164981ef3e436f148fd8adfb2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbffd93faacb3bdb2e41073e0c9dfcc2 |
| publicationDate | 1998-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-5840328-A |
| titleOfInvention | Treatment using arachidonic acid metabolite and particulate formulations |
| abstract | A composition comprises a free arachidonic acid metabolite and endocystosable particles such as phagocytosable or opsonizable particles, or particles binding to phagocytic receptors to serum proteins, and the like. The composition, in the form of a therapeutic formulation may be administered alone, or with other bioactive agents, for the treatment of a disorder characterized by cell activation/adhesion, inflammation or toxemia. A second method of treating such disorders comprises the administration of an endocytosable particle. |
| priorityDate | 1994-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 60.